Concepedia
Statistics
Publications
19
Citations
874
H-Index
16
Active since
1981
Affiliations
Jazz Pharmaceuticals (United States)(Current)
University of L'Aquila
University of Utah
Beth Israel Deaconess Medical Center
Harvard University
David Sherris is an author at Jazz Pharmaceuticals (United States) specializing in pharmacology, medicine, and life sciences.
Publications per year
1981–2019
Palomid 529, a Novel Small-Molecule Drug, Is a TORC1/TORC2 Inhibitor That Reduces Tumor Growth, Tumor Angiogenesis, and Vascular Permeability
Qi Xue, Benjamin D. Hopkins, Carole Perruzzi et al. · Cancer Research · 2008 · 105 citations · Full text
Medicine, Cancer Biology, Pharmacology +17
Potential Therapeutic Roles for Inhibition of the PI3K/Akt/mTOR Pathway in the Pathophysiology of Diabetic Retinopathy
David Sherris · Journal of Ophthalmology · 2011 · 90 citations · Full text
Medicine, Ophthalmology, Pharmacology +17
Lipopolysaccharide (LPS) Neutralizing Peptides Reveal a Lipid A Binding Site of LPS Binding Protein
Alexander H. Taylor, George A. Heavner, Mark Nedelman et al. · Journal of Biological Chemistry · 1995 · 74 citations · Full text
Life Sciences, Immunology, Molecular Biology +16
Posttranslational processing of methyl-accepting chemotaxis proteins in <i>Escherichia coli</i>
David Sherris, John S. Parkinson · Proceedings of the National Academy of Sciences · 1981 · 72 citations
Life Sciences, Microbiology, Molecular Biology +14
RhoB controls coordination of adult angiogenesis and lymphangiogenesis following injury by regulating VEZF1-mediated transcription
Damien Gerald, Irit Adini, Sharon Shechter et al. · Nature Communications · 2013 · 64 citations · Full text
Life Sciences, Cell Biology, Molecular Biology +16
1–5 of 19